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Cellular responses to pathogen invasion are crucial for maintaining cell 
homeostasis and survival. The interferon (IFN) system is one of the most 
effective cellular responses to viral intrusion in mammals. Viral recognition by 
innate immune sensors activates the antiviral IFN system. Retinoic 
acid-inducible gene I (RIG-I) like receptors (RLRs) are DExD/H box RNA 
helicases that sense viral invasion. RLRs recognize cytoplasmic viral RNAs 
and trigger antiviral responses, resulting in production of type I IFN and 
inflammatory cytokines. Unique and common sensing mechanisms among 
RLRs have been reported. In this review, recent progress in the understanding 




Virus infection induces numerous host responses to eliminate pathogen 
invasion. Host antiviral responses are operated by germline-encoded cellular 
receptors that recognize specific patterns of foreign molecules, termed 
pathogen-associated molecular patterns (PAMPs). PAMPs are detected by the 
‘sensor’ molecules, known as pattern recognition receptors (PRRs), which play 
a crucial role in triggering host innate immunity, a primary cellular defense 
system. Recent studies have identified several innate immune receptors 
including Toll-like receptors (TLRs), nucleotide-binding oligomerization domain 
(NOD)-like receptors (NLRs) and RLRs, and clarified their roles in antiviral 
signaling by sensing virus-derived molecules.  
In this review, we focus on RLRs, which detect cytoplasmic viral RNA PAMPs. 
For the function of TLRs and NLRs, refer to reviews published elsewhere [1] [2].  
RLR-mediated signaling 
RLRs are Asp-Glu-Ala-Asp (DEAD) box containing RNA helicases. To date, 
three members including RIG-I, melanoma differentiation-associated gene 5 
(MDA5) and laboratory of genetics and physiology 2 (LGP2) have been 
indentified. All RLRs share helicase domain and C-terminal domain (CTD), 
however LGP2 lacks a caspase activation and recruitment domain (CARD), 
that is critical for signal transduction; thus, LGP2 has been suggested as the 
regulatory molecule for RIG-I and MDA5 [3] [4].  
Upon viral infection, RLRs recognize PAMP RNAs (Table 1) and undergo 
conformational change mediated by ATPase/Helicase activity, which results in 
the exposure of CARD [5] [6]. Although RIG-I and MDA5 sense distinct viral 
infections [7] (Table 2), they share a common mitochondria-localized 
downstream signal adaptor, interferon promoter stimulator-1 (IPS-1, also 
termed MAVS, VISA or Cardif) for signal transduction [8]. Upon interaction 
between RLR and IPS-1 via their CARD-CARD association, IPS-1 conforms 
aggregates which share several features of prions [9]. The mitochondrial 
component, mitofusin 1 (MFN1) plays a critical role in the IPS-1 aggregation by 
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regulation of the mitochondrial fusion and fission [10]. This assembly further 
results in the recruitment of several ubiquitin ligases (TRAFs) and kinase 
complexes (TBK1 or IKKε and IKKα/β/γcomple x. A recent study suggested 
that GEF-H1, a microtubule network-associated protein, regulates the 
trafficking of IFN signaling by mediating the interaction between 
TBK1/IKKεa nd IRF3 [11]. Eventually, the activation of transcription factors 
IRF3 and IRF7, as well as NF-B, leads to the production of type I IFNs and 
pro-inflammatory cytokines [8] (Figure 1).  
 
The produced IFN becomes a messenger of the ‘warning sign’ for both 
IFN-producing and bystander cells, and promotes the ‘second round’ antiviral 
responses by inducing the expression of hundreds of interferon-stimulated 
genes (ISGs). The antiviral roles of several representative ISGs, such as PKR, 
OASs and RNase L, are well-characterized. Recent studies further elucidated 
the function of another ISG, IFITs, in their antiviral activity. IFITs, especially 
IFIT1, IFIT2 and IFIT5, recognize 5’ triphosphorylated (5’ ppp) RNA or capped 
RNA lacking 2’-O-methyl groups and sequester such RNA from translation, 
leading to the inhibition of viral replication [12] [13].   
RNA ligands of RIG-I 
1. Does RIG-I recognize RNA with 5’-triphosphate? 
In 2006, two groups simultaneously provided significant evidence that 
triphosphate moiety on the 5’ end is an essential determinant of RIG-I 
activation using single-stranded (ss) ‘in vitro transcribed’ RNA (ivtRNA) or a 
viral genome containing 5’ppp [14] [15] [16]. Rehwinkel et al. also proved that 
viral genomes bearing 5’ppp trigger IFN responses [17]. However, it became 
clearer in the following two studies that 5’ppp itself is not sufficient for efficient 
RIG-I activation [18] [19]. These reports commonly found that, unlike 5’ppp 
ivtRNA, chemically synthesized 5’ppp ssRNA did not activate RIG-I and they 
also realized that products of in vitro transcription by phage RNA polymerase 
retained the unexpected ‘copy-back’ structure. Therefore they concluded that 
an additional double-stranded region or a stem-loop structure is necessary for 
a true RIG-I agonist. Indeed, it was clarified that Sendai virus (SeV) and 
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vesicular stomatitis virus (VSV) produce RIG-I agonist RNA, known as a 
‘defective-interfering (DI) RNA’, which contains a copy-back structure with 
5’ppp [20] [21]. Moreover, recent studies showed that PAMP RNA from 
negative-strand ssRNA viruses, including influenza A, rabies, and measles 
virus, possess conserved panhandle structures with 5’ppp in their genomes, 
further confirming that 5’ppp along with secondary structures is an 
indispensable characteristic of RIG-I activators.  
2. dsRNA activates RLRs 
dsRNA is a classical non-self RNA, which is not produced in uninfected cells 
due to a lack of RNA-dependent RNA polymerase in mammalian cells. Both 
RIG-I and MDA5 appear to regulate the induction of type I IFN after stimulation 
by dsRNA [22]. Since artificial dsRNA, polyinosinic:polycytidylic acid (poly I:C), 
does not possess 5’ triphosphate, several studies using various 5’- or 
3’-modified dsRNAs also showed that 5’ppp is dispensable for RIG-I activation 
[5] [23]; it is generally assumed that recognition of dsRNA by RIG-I does not 
require 5’ppp. Interestingly, it was discovered that the length of dsRNA is a 
critical determinant that enables RNA ligands to turn on either RIG-I or MDA5 
activation [24]. It was revealed that short dsRNA (< 1 kb) elicited IFN 
production through RIG-I while long dsRNA (> 7 kb) failed to activate RIG-I, 
but efficiently activate MDA5. Related to the size-dependent activation of RIG-I 
by dsRNA, it is suggested that RIG-I conforms to a different structure when 
bound to short and long dsRNA [5].   
The dsRNA chain length-dependent recognition was confirmed by viral 
infection [24]. For example, viruses that produce undetectable (Influenza A 
virus) or short dsRNA (VSV) activate RIG-I-dependent signaling. In contrast, 
long dsRNA-producing viruses, such as encephalomyocarditis virus (EMCV) 
induce IFN signaling through MDA5. Interestingly, reovirus, whose genome is 
composed of different-sized segmented dsRNA, is recognized by both RIG-I 
and MDA5 [24].   
3. RNA sequence specificity  
Although sensing of dsRNA does not seem to require sequence specificity, the 
RNA sequence is an important feature for the recognition of 5’ppp RNAs by 
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RIG-I. Saito et al. found that 3’-untranslated region (3’ UTR) of the hepatitis C 
virus (HCV) genome (ssRNA) is a potent RIG-I activator [25]. On screening of 
the RIG-I activating domain by dissecting the HCV 3’UTR, they discovered that 
the uridine-rich region has the potential to trigger IFN signaling through RIG-I 
in a 5’ppp dependent manner. Nucleotide substitution analysis further revealed 
that adenosine-rich RNA also potentially activates RIG-I. Moreover, the 
authors also showed that IFN induction by the full-length HCV genome is 
dependent on 3’UTR in vivo, confirming that the uridine-rich sequence is a 
crucial PAMP for the recognition of HCV by RIG-I.   
4. PAMP production by host enzymes 
In 2009, two groups simultaneously reported that AT-rich dsDNA triggers IFN 
signaling through the RIG-I pathway [26] [27]. It was discovered that AT-rich, 
but not GC- or IC-rich dsDNA, is a template for RNA polymerase III that 
produces 5’ppp-containing AU-rich RNA. Since transcription may occur for 
both strands of a template, RNA transcripts are perfectly complementary, 
producing 5’ppp-dsRNA.   
By definition, ‘non-self RNAs’ are derived from a pathogen, however, one 
report suggests the conversion of ‘self RNAs’ into immune-stimulatory 
molecules. Malathi et al. discovered that small RNAs produced from the 
cleavage of both viral and host RNA by RNase L can activate interferon 
signaling through both RIG-I and MDA5 [28]. Cleaved products are small 
RNAs (< 200 nt) with 5’-hydroxyl (5’-OH) and 3’-monophosphoryl (3’-P) groups. 
Interestingly, loss of 3’-monophosphate abolished its ability to activate RLR, 
suggesting a 3’-monophosphate-dependent sensing mechanism for RLR 
signaling. The authors further suggested the requirement of a higher order 
structure in addition to 3’-P for this regulation [29].  
RNA ligands of MDA5 
1. MDA5 recognizes long dsRNA 
Compare to RIG-I ligands, very little is known about the biochemical 
specificities of ‘MDA5-activating’ RNA ligands. To date, several approaches 
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have elucidated that MDA5 mainly senses positive single-stranded RNA or 
dsRNA viruses, such as Picornaviridae, Caliciviridae, Togaviridae, Flaviviridae, 
and Reoviridae. While IFN induction by Picornaviridae and Caliciviridae 
exclusively detected by MDA5 [7] [30], MDA5 is partially involved in antiviral 
responses induced by Togaviridae [31], Flaviviridae [32] and Reoviridae [24]. 
These viruses produce or possess ‘long dsRNA’ and this is consistent with the 
central concept that MDA5 senses long dsRNA. Recently, Feng et al. 
suggested that MDA5 senses neither genomic RNA nor viral mRNA, but 
recognizes ‘replication intermediates’ generated during minus-strand RNA 
synthesis [33], further supporting the idea that long dsRNA is a critical 
determinant of an MDA5 ligands.  
2. RNA web 
In addition to length dependency, there is another hallmark of MDA5 ligand in 
relation to the RNA structure. Recently, Pichlmair et al. suggested the new 
concept that activation of MDA5 requires a ‘high-order’ RNA structure [34]. 
Interestingly, ‘pure’ long dsRNA (> 10 kb) generated by the viruses such as 
EMCV or vaccinia virus (VV) does not trigger IFN expression even though 
MDA5 interacts with it. However, ‘high molecular weight’ viral RNA that 
contains both ssRNA and dsRNA, robustly induces innate immune responses. 
Since MDA5 recognition of these RNAs does not require sequence specificity, 
they concluded that MDA5 activation requires an ‘RNA web’ rather than just 
‘simply long’ dsRNA. Since this result was confirmed with natural viral RNA, 
their finding may provide a significant clue for the identification of natural 
MDA5 ligand.  
3. Cooperation of RNase L for MDA5 sensing 
Interestingly, there is a recent report showing that MDA5 can recognize viral 
mRNA and induce IFN signaling. Luthra et al. showed that parainfluenza virus 
5 (PIV5) mRNA coding L protein can be converted to a potent MDA5 ligand by 
RNase L [35]. It is of interest to note that only a specific region of viral mRNA 
cleaved by RNase L activates MDA5, suggesting that MDA5 requires a 
specific RNA sequence or structure for recognition.  
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Contribution of LGP2 to RLR sensing 
Compared to other RLRs, the functional role of LGP2 in viral recognition is still 
not well understood. LGP2 was originally thought to function as a negative 
regulator of RLR signaling due to the lack of the signaling domain, CARDs [3]. 
Indeed, several earlier reports showed the negative regulation of RLR 
signaling by overexpression of LGP2 [3] [36]. However, two recent 
independent studies using a ‘LGP2-knockout’ system suggested a positive 
role of LGP2 in RLR sensing [4] [37]. These two studies confirmed impaired 
IFN production in LGP2-deficient cells by picornavirus, indicating that LGP2 
functions positively in MDA5-derived IFN signaling. However, the functional 
role of LGP2 in RIG-I-induced antiviral responses is inconsistent with these 
studies; thus, the contribution of LGP2 to sensing by RIG-I is controversial. It is 
proposed that LGP2 may cooperate with either MDA5 or RIG-I to transmit a 
signal to IPS-1 through their CARDs. Interestingly, LGP2 is dispensable for 
IFN production by synthetic RNA molecules such as poly I:C and 5’ppp RNA. 
Although ATPase activity of LGP2 is essential for this regulation [4], the exact 
mechanism of LGP2-mediated augmentation remains to be clarified. 
 
Post-translational modification: the mainspring of RLR signaling 
Upon viral infection, antiviral IFN signaling is immediately propagated through 
the cooperative association of multiple antiviral molecules. During the 
signaling cascade, antiviral proteins undergo various biochemical or physical 
modifications, such as oligomerization, ubiquitination and phosphorylation.   
It was reported that RIG-I and MDA5 are oligomerized upon ligand recognition. 
Indeed, artificial oligomerization of RIG-I using a chemical cross linker can 
activate an antiviral response without a virus or dsRNA stimulus [38]. Recent 
studies suggested that oligomerization of RIG-I occurs through its ATPase 
activity and is required for optimal RIG-I activation [39] [40]. Peisley et al. 
showed that RIG-I binds to the end region of dsRNA without ATP hydrolysis 
but upon ATP treatment, RIG-I forms a ‘filament-like’ oligomer along dsRNA 
[40]. Unlike RIG-I, however, MDA5 is capable of assembling a filament in an 
ATP-independent manner, suggesting distinct sensing mechanisms between 
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RIG-I and MDA5 [41]. In addition, Jiang et al. reported that lysine-63 (K63) 
poly-ubiquitination on the CARD domain induces a hetero-tetrameric complex 
of RIG-I and further elucidated that ubiquitin-induced RLR oligomerization is 
critical for downstream signal transduction [42]. Thus, oligomerization of RLR 
is a significant hallmark of RLR activation.  
The importance of K63 poly-ubuquitination on RIG-I by ubiquitin ligases 
TRIM25 and Riplet has been previously reported [43] [44]. Indeed, multiple 
ubiquitin ligases are involved in the regulation of innate immune signaling [45]. 
Upon K63 ubiquitination-mediated RIG-I/IPS-1 interaction, IPS-1 forms a 
fibril-like structure that converts ‘normal’ IPS-1 to ‘functional’ IPS-1, thus 
termed ‘prion-like-aggregates’, leading to the propagation of antiviral signaling 
[9]. Thus, ubiquitination seems to be a critical post-translational modification 
for governing the antiviral signaling from ‘RLR activation’ to ‘signal 
transduction’.  
Phosphorylation is one of the best-studied post-translational modifications that 
switch many cellular signaling pathways on and off. Indeed, several kinases 
are involved in IFN signaling and play crucial roles in host antiviral responses. 
dsRNA-dependent protein kinase (PKR) is a classic IFN-inducible antiviral 
protein that comprises a dsRNA-binding motif and a kinase domain [46]. 
Recently, it was suggested that PKR is a key factor for the induction of 
cytoplasmic bodies called ‘stress granule’ (SG) by viral infection and we further 
demonstrated that SGs provide a critical platform for interactions between 
antiviral proteins, including RLRs, DHX36, RNase L and OAS1, and non-self 
RNA ligands, thus termed ‘antiviral stress granule’ (avSG) [47] [48] [49] [50] 
(Figure 1) More recently, it was shown that the ubiquitin ligases TRIM25 and 
Riplet are co-localized with SG after viral infection or poly I:C transfection, 
further suggesting the significant role of avSG in RLR signal transduction [50] 
[44] (Figure 1).   
Viral evasion of RLR sensing 
The loser of the battle between a virus and host will face a ‘dead-end’, thus 
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arming it with a better strategy that is essential for survival. Recent reports 
showed multiple strategies of viruses to evade RLR sensing by encoding 
suppressors that target signaling molecules in antiviral responses. 
Several viral proteins directly target RLRs. For example, influenza virus NS1, a 
multifunctional antagonist of host immune responses [51], inhibits 
ubiquitination of RIG-I CARD by interrupting TRIM25 [52]. In addition, hijacking 
of RIG-I and TRIM25 by viral protein abrogates IFN signaling [53]. Moreover, it 
is known that V protein of paramyxoviridae member viruses directly binds to 
MDA5 and suppresses the function of MDA5 [54]. Critical signal adaptor, 
IPS-1 is also an attractive target of HCV that induce cleavage of IPS-1 by viral 
protease, NS3/4A [55]. Furthermore, function of downstream signal molecules 
such as TBK1 and IRF3 is also hampered by viral infection [56] [57] [58]. 
  
In addition to direct inhibition of the signaling molecules, several viruses also 
counteract IFN production by preventing or disrupting the formation of avSG. It 
is reported that influenza viral protein NS1 inhibits PKR activation to prevent 
avSG formation [47] [59]. EMCV also blocks antiviral signaling by disrupting 
avSG through cleavage of G3BP by viral protease 3C [48]. Furthermore, 
several viruses antagonize the induction of avSG formation by preventing 
dsRNA accumulation that would otherwise induces antiviral signaling [60] [61]. 
 
Conclusions  
It has been a decade since the ‘long-sought’ cytoplasmic viral sensors, RLRs, 
were identified. During the last decade, numerous efforts by colleagues in this 
field have advanced our understanding of the cytoplasmic antiviral sensing 
system. However, there are still unsolved fundamental questions that remain 
to be addressed.  
Although accumulated research has identified the essential properties of 
RLR-activating ligands, our knowledge is limited due to the physiological 
differences between ‘artificial’ and ‘natural’ RLR agonists. Therefore, it is 
important to investigate 1) what types of RNA are produced by different viral 
infections, 2) which RNA molecules from viral replication are truly responsible 
for RLR activation, 3) what is the exact molecular feature of RLR-activating 
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viral RNAs and 4) how each virus evades host immune responses. By 
understanding these issues, it may be possible to develop ‘order-made’ 
antiviral therapeutics or vaccines for ‘viral strain-specific’ clinical treatment. 
Another important issue to be considered is that, although major players in IFN 
signaling have been identified, the molecular mechanisms of signal 
transduction and termination are still poorly understood. Since autoimmune 
disorders are often related to the loss of ‘self-immune control’, understanding 
the precise molecular mechanisms of the signal transduction may enable us to 
target specific signal molecules to relieve ‘hypersensitive’ immune reactions. 
Finally, it would be also worth connecting RLRs to other applications, for 
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Figure 1. RLR signal pathway 
Upon viral infection, non-self RNAs, such as 5’ppp-containing structured RNA 
or dsRNA, are recognized by host cytoplasmic sensors, RLRs and PKR. 
Recognition of RNA ligands induces conformational changes of RLRs and 
PKR, leading to the initiation of downstream signaling cascades. Activated 
PKR immediately induces avSG, where antiviral proteins and signal molecules 
interact, and augments RLR signaling. E3 ubiquitin ligases-mediated 
CARD-CARD interaction between RLRs and IPS-1 recruits TRAFs and kinase 
complexes (TBK1 & IKKε) to facilitate IRF3 phosphorylation and nuclear 
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RNA types RNAs / Viruses Characteristics Sensor References
5' ppp copy-back RNA In vitro transcribed RNA RIG-I Schlee (2009), Schmidt (2009)
5'ppp AU-rich RNA Pol III product from poly dA:dT RIG-I Ablasser (2009), Chiu (2009)
poly I:C short Short dsRNA (< 1 kb) RIG-I Kato (2008)
poly I:C long Long dsRNA (> 7 kb) MDA5 Kato (2008)
IAV genomic RNA 5' ppp with panhandle structure RIG-I Rehwinkel (2010)
HCV 3'UTR U/UC rich RNA 5' ppp dependent RIG-I Saito (2008)
IAV 3'UTR U/A rich RNA 5' ppp independent RIG-I Davis (2012)
SeV, VSV DI RNA 5' ppp copy-back dsRNA RIG-I Strahle (2006), Patel (2013), Panda (2010)
VV, EMCV High molecular weight RNA MDA5 Pichlmair (2009)
CVB3, Mengo Replication intermediates MDA5 Feng (2012)
PIV5 L mRNA RNase L product MDA5 Luthra (2011)
EMCV L antisense LGP2-interacting RNA MDA5 / LGP2 Deddouche (2014)





Sensor Viruses Families / Genome References
Newcastle disease virus Kato (2006)
Sendai virus Yoneyama (2004), Kato (2006)
Respiratory syncytical virus Loo (2008)
Vesicular stomatitis virus Yoneyama (2005), Kato (2006)
Rabies virus Hornung (2006)
Influenza A virus Kato (2006)
Influenza B virus Loo (2008)
Rift Valley fever virus Weber (2013)
La Crosse virus Weber (2013)
Hepatitis C virus Saito (2008)
Japanese encephalitis virus Kato (2006)
Epstein-Barr virus Gammaherpesviridae / dsDNA Samanta (2008)
Encephalomyocarditis virus Kato (2006)
Theiler's murine encephalitis virus Kato (2006)
Mengovirus Kato (2006)
Coxackie virus Feng (2012)
Entero virus Feng (2012)
Human Parechovirus Feng (2012)
Equine Rhinitis A virus Feng (2012)
Saffold virus Feng (2012)
Norovirus Caliciviridae / (+) ssRNA, non-segmented McCartney (2008)
Vaccinia virus Poxviridae / dsDNA Pichlmair (2009)
Westnile virus Loo (2008)
Dengue viurs Loo (2008)
Measles virus Paramyxoviridae / (-) ssRNA, non-segmented Satoshi (2010)
Semliki forest virus Togaviridae / (+) ssRNA, non-segmented Schulz (2010)
MDA5
Picornaviridae / (+) ssRNA, non-segmented
RIG-I / MDA5
Flaviviridae / (+) ssRNA, non-segmented
List of viruses and their known sensors
RIG-I
Paramyxoviridae / (-) ssRNA, non-segmented
Rhabdoviridae / (-) ssRNA, non-segmented
Orthomyxoviridae / (-) ssRNA, segmented
Bunyaviridae / (-) ssRNA, segmented
Flaviviridae / (+) ssRNA, non-segmented
